S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82

Exponent Stock Forecast, Price & News

-1.32 (-1.12%)
(As of 11/30/2021 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
220,610 shs
Average Volume
188,319 shs
Market Capitalization
$6.07 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive EXPO News and Ratings via Email

Sign-up to receive the latest news and ratings for Exponent and its competitors with MarketBeat's FREE daily newsletter.

Exponent logo

About Exponent

Exponent, Inc. is an engineering and scientific consulting company, which engages in the provision of engineering, scientific, environmental, and health consulting services. It operates through the following segments: Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment include technical consulting in different practices primarily in engineering. The Environmental and Health segment offers services in the area of environmental, epidemiology, and health risk analysis. The company was founded by Bernard Ross in 1967 and is headquartered in Menlo Park, CA.


See More Headlines

Industry, Sector and Symbol

Management consulting services
Research & Consulting Services
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$399.90 million
Cash Flow
$1.73 per share
Book Value
$7.00 per share


Net Income
$82.55 million
Pretax Margin




Free Float
Market Cap
$6.07 billion

Company Calendar

Dividend Payable
Last Earnings
Fiscal Year End
Next Earnings (Estimated)

Social Links


Overall MarketRank

2.14 out of 5 stars

Business Services Sector

126th out of 423 stocks

Management Consulting Services Industry

10th out of 26 stocks

Analyst Opinion: 1.5Community Rank: 4.4Dividend Strength: 1.7Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -

Exponent (NASDAQ:EXPO) Frequently Asked Questions

Is Exponent a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Exponent stock.
View analyst ratings for Exponent
or view top-rated stocks.

How has Exponent's stock price been impacted by COVID-19 (Coronavirus)?

Exponent's stock was trading at $75.99 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, EXPO shares have increased by 53.3% and is now trading at $116.50.
View which stocks have been most impacted by COVID-19

Are investors shorting Exponent?

Exponent saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 563,600 shares, a decrease of 30.3% from the October 31st total of 809,000 shares. Based on an average daily trading volume, of 169,000 shares, the short-interest ratio is presently 3.3 days. Approximately 1.1% of the shares of the company are sold short.
View Exponent's Short Interest

When is Exponent's next earnings date?

Exponent is scheduled to release its next quarterly earnings announcement on Thursday, February 3rd 2022.
View our earnings forecast for Exponent

How were Exponent's earnings last quarter?

Exponent, Inc. (NASDAQ:EXPO) issued its earnings results on Thursday, October, 28th. The business services provider reported $0.46 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.39 by $0.07. The business services provider earned $116.41 million during the quarter, compared to the consensus estimate of $104.01 million. Exponent had a trailing twelve-month return on equity of 26.81% and a net margin of 22.51%. The company's revenue was up 18.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.34 earnings per share.
View Exponent's earnings history

How often does Exponent pay dividends? What is the dividend yield for Exponent?

Exponent declared a quarterly dividend on Thursday, October 28th. Shareholders of record on Friday, December 3rd will be paid a dividend of $0.20 per share on Friday, December 17th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.69%. The ex-dividend date of this dividend is Thursday, December 2nd.
View Exponent's dividend history

Is Exponent a good dividend stock?

Exponent pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.68%. Exponent has been increasing its dividend for 3 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of Exponent is 41.45%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Exponent will have a dividend payout ratio of 40.40% next year. This indicates that Exponent will be able to sustain or increase its dividend.
View Exponent's dividend history.

When did Exponent's stock split? How did Exponent's stock split work?

Exponent's stock split on the morning of Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly issued shares were payable to shareholders after the market closes on Wednesday, June 6th 2018. An investor that had 100 shares of Exponent stock prior to the split would have 200 shares after the split.

What price target have analysts set for EXPO?

2 brokers have issued 12 month price objectives for Exponent's shares. Their forecasts range from $126.00 to $126.00. On average, they anticipate Exponent's share price to reach $126.00 in the next year. This suggests a possible upside of 8.2% from the stock's current price.
View analysts' price targets for Exponent
or view top-rated stocks among Wall Street analysts.

Who are Exponent's key executives?

Exponent's management team includes the following people:
  • Catherine Ford Corrigan, President, Chief Executive Officer & Director
  • Richard L. Schlenker, Chief Financial Officer, Secretary & Executive VP
  • Subbaiah V. Malladi, Chief Technical Officer
  • Suresh H. Moolgavkar, Vice President
  • Eric R. Anderson, Vice President & Controller

What is Catherine Corrigan's approval rating as Exponent's CEO?

15 employees have rated Exponent CEO Catherine Corrigan on Glassdoor.com. Catherine Corrigan has an approval rating of 84% among Exponent's employees.

What other stocks do shareholders of Exponent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exponent investors own include AbbVie (ABBV), Pfizer (PFE), Abbott Laboratories (ABT), Energy Transfer (ET), Ford Motor (F), Micron Technology (MU), AT&T (T), UnitedHealth Group (UNH), Visa (V) and Adobe (ADBE).

What is Exponent's stock symbol?

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

Who are Exponent's major shareholders?

Exponent's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.68%), Neuberger Berman Group LLC (6.16%), Kayne Anderson Rudnick Investment Management LLC (4.99%), Conestoga Capital Advisors LLC (3.98%), Geneva Capital Management LLC (2.44%) and Dimensional Fund Advisors LP (2.03%). Company insiders that own Exponent stock include Bradley A James, Carol Lindstrom, Harri Kytomaa, John Pye, Maureen T F Reitman, Paul R Johnston, Paul R Johnston, Richard L Schlenker Jr, Richard Reiss, Sally Shepard and Steven J Murray.
View institutional ownership trends for Exponent

Which major investors are selling Exponent stock?

EXPO stock was sold by a variety of institutional investors in the last quarter, including Roffman Miller Associates Inc. PA, BlackRock Inc., Millennium Management LLC, Renaissance Technologies LLC, Morgan Stanley, Ardevora Asset Management LLP, Copeland Capital Management LLC, and Neuberger Berman Group LLC. Company insiders that have sold Exponent company stock in the last year include Bradley A James, Carol Lindstrom, Harri Kytomaa, John Pye, Maureen T F Reitman, Paul R Johnston, and Steven J Murray.
View insider buying and selling activity for Exponent
or view top insider-selling stocks.

Which major investors are buying Exponent stock?

EXPO stock was acquired by a variety of institutional investors in the last quarter, including Kayne Anderson Rudnick Investment Management LLC, Schroder Investment Management Group, Marshall Wace LLP, Goldman Sachs Group Inc., Conestoga Capital Advisors LLC, Redwood Investments LLC, Raymond James & Associates, and BNP Paribas Arbitrage SA.
View insider buying and selling activity for Exponent
or or view top insider-buying stocks.

How do I buy shares of Exponent?

Shares of EXPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Exponent's stock price today?

One share of EXPO stock can currently be purchased for approximately $116.50.

How much money does Exponent make?

Exponent has a market capitalization of $6.07 billion and generates $399.90 million in revenue each year. The business services provider earns $82.55 million in net income (profit) each year or $1.93 on an earnings per share basis.

How many employees does Exponent have?

Exponent employs 1,168 workers across the globe.

Does Exponent have any subsidiaries?

The following companies are subsidiares of Exponent: Dennis Publishing.

When was Exponent founded?

Exponent was founded in 1967.

What is Exponent's official website?

The official website for Exponent is www.exponent.com.

Where are Exponent's headquarters?

Exponent is headquartered at 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025.

How can I contact Exponent?

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The business services provider can be reached via phone at (650) 326-9400, via email at [email protected], or via fax at 650-326-8072.

This page was last updated on 12/1/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.